Skip to content
Dx

ICD-10-CM 2027 diagnosis code

Q87.19Other congenital malformation syndromes predominantly associated with short stature

✓ Billable / specificPOA exemptCC — complication/comorbidity

Q87.19 is a valid, billable ICD-10-CM code for other congenital malformation syndromes predominantly associated with short stature. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Other congen malform synd predom assoc with short stature

Looking up by condition? See ICD-10 code for Ullrich syndrome, ICD-10 code for Noonan's syndrome, ICD-10 code for Seckel's syndrome, ICD-10 code for Silver's syndrome.

Code last changed in FY2020 (effective October 1, 2019). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About Q87.19

Q87.19 is the ICD-10-CM diagnosis code for other congenital malformation syndromes predominantly associated with short stature. It belongs to category Q87 (other specified congenital malformation syndromes affecting multiple systems), block Q80-Q89 (other congenital malformations) and chapter 17 (congenital malformations, deformations, chromosomal abnormalities, and genetic disorders). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within Q87.1, choose Q87.19 (Other congenital malformation syndromes predominantly associated with short stature) only when documentation doesn't support a more specific option: Prader-Willi syndrome (Q87.11).

Use an additional code(s) to identify all associated manifestations.

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 564 (Other Musculoskeletal System and Connective Tissue Diagnoses with MCC, relative weight 1.4908), DRG 565 (Other Musculoskeletal System and Connective Tissue Diagnoses with CC, relative weight 0.9783) and DRG 566 (Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC, relative weight 0.7378), in MDC 08 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.

It was added in FY2020, effective October 1, 2019.

Coding notes

Applicable toConditions and synonyms classified to this code
  • Aarskog syndrome
  • Cockayne syndrome
  • De Lange syndrome
  • Dubowitz syndrome
  • Noonan syndrome
  • Robinow-Silverman-Smith syndrome
  • Russell-Silver syndrome
  • Seckel syndrome

Notes that apply from higher levels

Instructions written at a parent level also apply to Q87.19.

› From Q87.1 Congenital malformation syndromes predominantly associated with short stature
Excludes1
  • Ellis-van Creveld syndrome (Q77.6)
  • Smith-Lemli-Opitz syndrome (E78.72)
› From Q87 Other specified congenital malformation syndromes affecting multiple systems
Use additional code
  • code(s) to identify all associated manifestations

Broader instructions also apply from Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders.

Alphabetic index entries

20 entries

Terms in the official ICD-10-CM index that lead to Q87.19.

Codes whose notes reference Q87.19

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2020 (effective 10/1/2019): Added
  • No changes since FY2020.

Common questions about Q87.19

Is Q87.19 billable?

Yes. Q87.19 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can Q87.19 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict Q87.19 as a principal diagnosis.

Is Q87.19 a CC or MCC?

Q87.19 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.

What DRG does Q87.19 group to?

Q87.19 is used in the MS-DRG v44.0 logic for MS-DRG 564 (Other Musculoskeletal System and Connective Tissue Diagnoses with MCC), MS-DRG 565 (Other Musculoskeletal System and Connective Tissue Diagnoses with CC) and MS-DRG 566 (Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.